Experience of an NIHR Clinical Lectureship (medical/dental) and the determining factors for a clinical academic career post lectureship: a mixed-method evaluation.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
17 11 2023
Historique:
medline: 20 11 2023
pubmed: 18 11 2023
entrez: 17 11 2023
Statut: epublish

Résumé

The objective of this study is to investigate early-to-late postdoctoral clinical academic progression and the experiences of NIHR Clinical Lectureship (CL) fellows, considering enablers and barriers to success, and identifying the factors associated with immediate progression to a clinical academic role following completion of the award. Datasets of CL awardees across the UK. For semistructured interviews, n=40 CL awardees that had finished their award within the previous 5 years. For quantitative analysis, n=1226 completed or currently active CL awardees. The responses from the semistructured interviews to the defined questions on experiences during the award, postaward progression, and enablers and barriers to academic progression. Other primary outcome measures were quantitative data on first destinations postaward, demographic data, and whether an awardee had previously held an NIHR Academic Clinical Fellowship (ACF) or was a recipient of the Academy of Medical Sciences (AMS) Starter Grant. CL awardees identified numerous benefits to the award, with the majority achieving their aims. Most awardees progressed to a clinical academic role; however, some returned to a clinical only position, citing concerns around the time pressure associated with balancing clinical and academic responsibilities, and the competition to attain further postdoctoral awards. The region of the award partnership, year of award end and success in applying for an AMS Starter Grant were associated with progression to a clinical academic role. Gender, holding an ACF and having a craft or non-craft specialty had no independent statistical association with clinical academic progression. The CL is a valued element of the Integrated Academic Pathway. By addressing issues around later postdoctoral progression opportunities, responding to challenges experienced by CLs, and by understanding the factors identified in this study associated with clinical academic progression, it should be possible to increase the proportion of CLs that become fully independent clinical academic research leaders. 1226 NIHR CLs active or completed on the award between 2006 and 2020.

Identifiants

pubmed: 37977870
pii: bmjopen-2022-070536
doi: 10.1136/bmjopen-2022-070536
pmc: PMC10660434
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e070536

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JH, MRM and HH were employed by the University of Leeds while working on the manuscript, JH was a member then Chair of a selection panel for NIHR Academy Fellowships between 2006 and 2014. MMR and CM are employed by the Academy of Medical Sciences. The remaining authors are all employed by NIHR CC.

Références

Acad Med. 2018 Nov;93(11):1686-1693
pubmed: 29369085
BMJ Open. 2016 Oct 21;6(10):e013523
pubmed: 27798036
Med Teach. 2011;33(11):e637-43
pubmed: 22022917
Int J Transgend Health. 2022 Oct 25;24(1):1-6
pubmed: 36713144
BMJ Open. 2021 Apr 1;11(4):e043270
pubmed: 33795298
BMJ Open. 2017 Jun 12;7(6):e015722
pubmed: 28606905
PLoS Med. 2019 Oct 15;16(10):e1002935
pubmed: 31613898
BMJ Open. 2018 Mar 3;8(3):e020398
pubmed: 29502093
BMJ Open. 2022 Jun 8;12(6):e057655
pubmed: 35676023
Med Sci Educ. 2022 Feb 16;32(2):503-509
pubmed: 35194524
Lancet. 2016 Feb 25;387 Suppl 1:S3-5
pubmed: 26923275
BMJ Open. 2022 Jan 13;12(1):e046368
pubmed: 35027412
BMJ Open. 2012 Aug 30;2(4):
pubmed: 22936819
BMJ Open. 2020 Mar 25;10(3):e033480
pubmed: 32213518
BMJ. 2000 Mar 4;320(7235):630-3
pubmed: 10698887
BMJ Open. 2022 Sep 8;12(9):e060281
pubmed: 36691216
Clin Med (Lond). 2004 Nov-Dec;4(6):483-8
pubmed: 15656470
J Gen Intern Med. 2013 Dec;28(12):1596-603
pubmed: 23765289
Ulster Med J. 2014 Sep;83(3):141-5
pubmed: 25484462
BMJ Open. 2022 Jan 13;12(1):e046410
pubmed: 35027413
BMC Med Educ. 2021 Aug 16;21(1):432
pubmed: 34399743
Clin Med (Lond). 2007 Jan-Feb;7(1):79-81
pubmed: 17348582

Auteurs

Chris James Stevenson (CJ)

Academy, National Institute for Health and Care Research, Leeds, UK.

Helen Harris-Joseph (H)

Academy, National Institute for Health and Care Research, Leeds, UK helen.harris-joseph@nihr.ac.uk.

Lorraine Harper (L)

Academy, National Institute for Health and Care Research, Leeds, UK.
Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
University Hospitals Birmingham, NHS Foundation Trust, Birmingham, UK.

Jenny Hewison (J)

School of Medicine, University of Leeds Leeds Institute of Health Sciences, Leeds, UK.

Matthew R Mulvey (MR)

School of Medicine, University of Leeds Leeds Institute of Health Sciences, Leeds, UK.

Hein Heuvelman (H)

School of Medicine, University of Leeds Leeds Institute of Health Sciences, Leeds, UK.
Department of Public Health, Policy and Systems, Institute of Population Health, University of Liverpool, Liverpool, Lancashire, UK.

Clare McVicker (C)

Academy of Medical Sciences (AMS), London, UK.

Maria Magdalena Razalan (MM)

Academy of Medical Sciences (AMS), London, UK.

Emma Knowles (E)

Academy, National Institute for Health and Care Research, Leeds, UK.

Brad Ebanks (B)

Academy, National Institute for Health and Care Research, Leeds, UK.

Kieran Lee (K)

Academy, National Institute for Health and Care Research, Leeds, UK.

James Fenton (J)

Academy, National Institute for Health and Care Research, Leeds, UK.

Peter Thompson (P)

Academy, National Institute for Health and Care Research, Leeds, UK.

Lisa Ann Cotterill (LA)

Academy, National Institute for Health and Care Research, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH